Effects of a culturally tailored patient navigation program on unmet supportive care needs in Hispanic/Latino cancer survivors: A randomized controlled trial.

Blanca S Noriega Esquives, Patricia I Moreno, Edgar Munoz, Thomas E Lad, Courtney M P Hollowell, Roberto M Benzo, Amelie G Ramirez, Frank J Penedo
Author Information
  1. Blanca S Noriega Esquives: Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida, USA. ORCID
  2. Patricia I Moreno: Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, Florida, USA. ORCID
  3. Edgar Munoz: Department of Population Health Sciences, Institute for Health Promotion Research, University of Texas Health San Antonio, San Antonio, Texas, USA.
  4. Thomas E Lad: Department of Oncology, Cook County Health, Chicago, Illinois, USA.
  5. Courtney M P Hollowell: Department of Urologic Surgery, Cook County Health, Chicago, Illinois, USA.
  6. Roberto M Benzo: Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio, USA.
  7. Amelie G Ramirez: Department of Population Health Sciences, Institute for Health Promotion Research, University of Texas Health San Antonio, San Antonio, Texas, USA. ORCID
  8. Frank J Penedo: Department of Psychology, University of Miami, Coral Gables, Florida, USA. ORCID

Abstract

BACKGROUND: Patient navigation (PN) is a promising yet underused approach to address Hispanic/Latino (H/L) cancer survivors' unmet supportive care needs. The authors conducted a randomized trial to evaluate the effect of a culturally tailored PN program with the LIVESTRONG Foundation's Cancer Navigation Services (PN-LCNS) on reducing unmet needs in H/L survivors.
METHODS: From 2012 to 2015 at two US sites, 288 H/L survivors diagnosed with breast, prostate, or colorectal cancer were randomized to a PN-LCNS program or to standard PN. Participants assigned to the PN-LCNS program received 3-month PN services; access to phone-based, bilingual, one-on-one support; and additional resources (i.e., guidebook, health journal, and care plan). Participants completed assessments at baseline and at 3, 9, and 15 months post-baseline. The Supportive Care Needs Survey was used to assess unmet needs across five domains: psychological, health system and information, physical and daily living, patient care and support, and sexuality. Intervention effects were tested by using separate multilevel growth models for women and men.
RESULTS: Women randomized to the PN-LCNS program, relative to those who received standard PN, had a statistically significant reduction in unmet needs (i.e., overall and for the health systems and information, physical and daily living, and patient care and support domains). Among men, younger age was associated with greater unmet needs at baseline. Prostate cancer survivors reported greater unmet sexual health needs compared with colorectal cancer survivors. There was no significant change in unmet needs among H/L men.
CONCLUSIONS: A culturally tailored PN program can reduce unmet supportive care needs among H/L women cancer survivors. However, interventions specifically targeting unmet needs in H/L men and sexual health are still necessary (ClinicalTrials.gov identifier NCT02275754).
PLAIN LANGUAGE SUMMARY: Hispanic/Latino (H/L) cancer survivors often report concerns or needs that are not adequately addressed by the health care team, which could be related to psychological, health system and information, patient care and support, physical and daily living, and sexuality issues. In this randomized controlled trial of 288 H/L survivors diagnosed with breast, prostate, or colorectal cancer, women assigned to a culturally tailored patient navigation program experienced a reduction in unmet needs compared with those who received standard patient navigation. H/L men did not experience a change in unmet needs.

Keywords

Associated Data

ClinicalTrials.gov | NCT02275754

References

  1. Cancer. 2000 Jan 1;88(1):226-37 [PMID: 10618627]
  2. Contemp Clin Trials. 2019 Jan;76:41-48 [PMID: 30399442]
  3. Cancer. 2019 Aug 15;125(16):2747-2761 [PMID: 31034604]
  4. Cancer. 2022 May 1;128(9):1820-1825 [PMID: 35128638]
  5. Support Care Cancer. 2022 Feb;30(2):1483-1491 [PMID: 34529142]
  6. Clin Transl Oncol. 2023 Dec;25(12):3369-3377 [PMID: 37633856]
  7. Semin Oncol Nurs. 2023 Jun;39(3):151353 [PMID: 36435657]
  8. Qual Life Res. 2020 Oct;29(10):2615-2630 [PMID: 32430782]
  9. Support Care Cancer. 2017 Jan;25(1):209-212 [PMID: 27614868]
  10. Curr Oncol Rep. 2022 Jun;24(6):763-773 [PMID: 35286555]
  11. JAMA Netw Open. 2023 Jun 1;6(6):e2319352 [PMID: 37342038]
  12. Curr Oncol. 2023 Sep 25;30(10):8720-8762 [PMID: 37887531]
  13. Cancer Epidemiol Biomarkers Prev. 2019 Feb;28(2):384-391 [PMID: 30333221]
  14. Cancer. 2011 Aug;117(15 Suppl):3539-42 [PMID: 21780088]
  15. Support Care Cancer. 2019 Apr;27(4):1383-1394 [PMID: 30136022]
  16. Patient Educ Couns. 2010 Aug;80(2):241-7 [PMID: 20006459]
  17. J Clin Oncol. 2009 Jun 10;27(17):2758-65 [PMID: 19403886]
  18. Cancer. 2007 Jan 15;109(2 Suppl):446-54 [PMID: 17123273]
  19. J Natl Cancer Inst. 2014 Jun 17;106(6):dju115 [PMID: 24938303]
  20. Qual Life Res. 2020 Oct;29(10):2641-2650 [PMID: 32356277]
  21. Rev Invest Clin. 2017 Mar-Apr;69(2):114-22 [PMID: 28453509]
  22. J Sex Med. 2020 Jul;17(7):1326-1358 [PMID: 32331967]
  23. J Chronic Dis. 1987;40(5):373-83 [PMID: 3558716]
  24. BJU Int. 2016 Jun;117(6B):E10-9 [PMID: 25818406]
  25. Support Care Cancer. 2012 Jun;20(6):1275-81 [PMID: 21691847]
  26. Cancer. 2025 Jan 1;131(1):e35626 [PMID: 39487386]
  27. Cancer Control. 2008 Jan;15(1):55-62 [PMID: 18094661]
  28. Eur J Cancer Care (Engl). 2022 Jan;31(1):e13525 [PMID: 34729855]
  29. J Clin Oncol. 2012 Oct 20;30(30):3712-9 [PMID: 23008322]
  30. J Eval Clin Pract. 2009 Aug;15(4):602-6 [PMID: 19522727]
  31. Health Promot Pract. 2021 Jan;22(1):112-121 [PMID: 31874564]
  32. BMC Prim Care. 2024 Jan 20;25(1):30 [PMID: 38245674]
  33. Cancer. 2007 Aug 1;110(3):631-9 [PMID: 17592828]
  34. Health Equity. 2017 May 01;1(1):61-76 [PMID: 28905047]
  35. Cancer. 2020 Mar 1;126(5):1112-1123 [PMID: 31743436]
  36. Int J Palliat Nurs. 2018 Oct 2;24(10):510-514 [PMID: 30354899]
  37. Qual Life Res. 2008 Jun;17(5):665-77 [PMID: 18493865]
  38. Oncologist. 2021 Feb;26(2):157-164 [PMID: 33210345]
  39. Cancer. 2019 Feb 1;125(3):473-481 [PMID: 30508291]
  40. JBI Database System Rev Implement Rep. 2016 Feb;14(2):295-321 [PMID: 27536800]

Grants

  1. T32 CA251064/NCI NIH HHS
  2. U54 CA153511/NCI NIH HHS
  3. T32CA251064/NCI NIH HHS
  4. U54CA153511/NCI NIH HHS

MeSH Term

Adult
Aged
Female
Humans
Male
Middle Aged
Breast Neoplasms
Cancer Survivors
Colorectal Neoplasms
Culturally Competent Care
Health Services Needs and Demand
Hispanic or Latino
Patient Navigation
Prostatic Neoplasms
Social Support

Word Cloud

Created with Highcharts 10.0.0unmetneedsH/LcancercareprogramsurvivorshealthpatientPNnavigationrandomizedmensupportiveculturallytailoredPN-LCNSsupportHispanic/Latinotrialcolorectalstandardreceivedinformationphysicaldailylivingwomen288diagnosedbreastprostateParticipantsassignediebaselinepsychologicalsystemsexualitysignificantreductiongreatersexualcomparedchangeamongcontrolledBACKGROUND:Patientpromisingyetunderusedapproachaddresssurvivors'authorsconductedevaluateeffectLIVESTRONGFoundation'sCancerNavigationServicesreducingMETHODS:20122015twoUSsites3-monthservicesaccessphone-basedbilingualone-on-oneadditionalresourcesguidebookjournalplancompletedassessments3915monthspost-baselineSupportiveCareNeedsSurveyusedassessacrossfivedomains:InterventioneffectstestedusingseparatemultilevelgrowthmodelsRESULTS:WomenrelativestatisticallyoverallsystemsdomainsAmongyoungerageassociatedProstatereportedCONCLUSIONS:canreduceHoweverinterventionsspecificallytargetingstillnecessaryClinicalTrialsgovidentifierNCT02275754PLAINLANGUAGESUMMARY:oftenreportconcernsadequatelyaddressedteamrelatedissuesexperiencedexperienceEffectssurvivors:HispanicLatinosurvivorshipneed

Similar Articles

Cited By